These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1861963)

  • 1. [Tetracycline resistance in oral microorganisms in patients with periodontal disease].
    Olsvik B
    Nor Tannlaegeforen Tid; 1991 Jan; 101(2):50-2. PubMed ID: 1861963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy. A viable periodontal treatment modality?
    Deasy MJ
    Dent Clin North Am; 1990 Jan; 34(1):1-11. PubMed ID: 2403938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial agents in the treatment of periodontal diseases: special aspects on tetracycline and doxycycline.
    Heimdahl A; Nord CE
    Scand J Infect Dis Suppl; 1988; 53():35-45. PubMed ID: 3047856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic management of periodontal diseases using systemically administered agents.
    Mariotti A; Monroe PJ
    Dent Clin North Am; 1998 Apr; 42(2):245-62. PubMed ID: 9597336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial approaches to periodontal therapy].
    Vitaya CT
    J Dent Assoc Thai; 1990; 40(2):83-91. PubMed ID: 2074322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracycline resistance in periodontal pathogens.
    Olsvik B; Tenover FC
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S310-3. PubMed ID: 8324137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mobility and distribution of tetracycline resistance determinants.
    Roberts MC
    Ciba Found Symp; 1997; 207():206-18; discussion 219-22. PubMed ID: 9189643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local antimicrobial therapies in periodontal disease.
    Kinane DF
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():57-60. PubMed ID: 11709978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility of bacteria isolated from active, therapy-resistant periodontal sites.
    De Luca M
    Chemioterapia; 1988 Oct; 7(5):309-12. PubMed ID: 3147149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of bacterial resistance to tetracyclines in the treatment of periodontal diseases.
    Greenstein G
    J Periodontol; 1995 Nov; 66(11):925-32. PubMed ID: 8558393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracycline: levels of achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part II. Susceptibilities of periodontal bacteria.
    Walker CB; Gordon JM; McQuilkin SJ; Niebloom TA; Socransky SS
    J Periodontol; 1981 Oct; 52(10):613-6. PubMed ID: 7028940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy.
    Rodrigues RM; Gonçalves C; Souto R; Feres-Filho EJ; Uzeda M; Colombo AP
    J Clin Periodontol; 2004 Jun; 31(6):420-7. PubMed ID: 15142209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic resistance in the subgingival microflora in patients with adult periodontitis. A comparative survey between Spain and the Netherlands].
    van Winkelhoff AJ; Herrera D; Winkel EG; Dellemijn-Kippuw N; Vandenbroucke-Grauls CM; Sanz M
    Ned Tijdschr Tandheelkd; 1999 Aug; 106(8):290-4. PubMed ID: 11930422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of integrons and tetracycline resistance determinants in Aeromonas spp. isolated from South African aquaculture systems.
    Jacobs L; Chenia HY
    Int J Food Microbiol; 2007 Mar; 114(3):295-306. PubMed ID: 17173998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Odontogenic bacteria in periodontal disease and resistance patterns to common antibiotics used as treatment and prophylaxis in odontology in Spain.
    Maestre JR; Bascones A; Sánchez P; Matesanz P; Aguilar L; Giménez MJ; Pérez-Balcabao I; Granizo JJ; Prieto J
    Rev Esp Quimioter; 2007 Mar; 20(1):61-7. PubMed ID: 17530037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced repair and regeneration of periodontal lesions in tetracycline-treated patients. Case reports.
    Moskow BS; Tannenbaum P
    J Periodontol; 1991 May; 62(5):341-50. PubMed ID: 1649289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high-risk patients: antimicrobial activity and collagenase inhibition.
    McCulloch CA; Birek P; Overall C; Aitken S; Lee W; Kulkarni G
    J Clin Periodontol; 1990 Oct; 17(9):616-22. PubMed ID: 2174446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of systemic antibiotics in the treatment of aggressive periodontal disease.
    Seiler JS; Herold RW
    Gen Dent; 2005; 53(2):155-9; quiz 160, 145-6. PubMed ID: 15833018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ins and outs of periodontal antimicrobial therapy.
    Jorgensen MG; Slots J
    J Calif Dent Assoc; 2002 Apr; 30(4):297-305. PubMed ID: 12005374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of oral hygiene in patients with fixed appliances in the oral carriage of antimicrobial-resistant Escherichia coli and Enterococcus isolates.
    Poeta P; Igrejas G; Gonçalves A; Martins E; Araújo C; Carvalho C; Rodrigues J; Vinué L; López M; Torres C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):557-64. PubMed ID: 19778742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.